Effect of denosumab on bone mineral density and bone turnover markers: 48-month results

被引：0
|
作者：
Miller, P. [1 ]
Bolognese, M. [2 ]
Lewiecki, E. M. [3 ]
McClung, M. [4 ]
Ding, B. [5 ]
Liu, Y. [5 ]
Martin, J. San [5 ]
机构：
[1] Colorado Ctr Bone Res, Lakewood, CO USA
[2] Bethesda Hlth Res Ctr, Bethesda, MD USA
[3] New Mexico Clin Res & Osteoporosis Ctr, Albuquerque, NM USA
[4] Oregon Osteoporosis Ctr, Portland, OR USA
[5] Amgen Inc, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2007年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1205
引用
收藏
页码：S58 / S58
页数：1
相关论文
共 50 条
  • [31] Influence of vitamin D status on the effect of statins on bone mineral density and bone turnover markers
    Gonzalez-Macias, Jesus
    Hernandez, Jose L.
    Martinez, Josefina
    Ruiz, Sheila
    Olmos, Jose
    JOURNAL OF BONE AND MINERAL RESEARCH, 2013, 28
  • [32] Effect of Epidural Steroid Injection on Bone Mineral Density and Markers of Bone Turnover in Postmenopausal Women
    Al-Shoha, Ahmad
    Rao, D. Sudhaker
    Schilling, Jennifer
    Peterson, Edward
    Mandel, Shlomo
    SPINE, 2012, 37 (25) : E1567 - E1571
  • [33] Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis
    Kato, Kazuhiko
    Yaginuma, Tatsuhiro
    Kobayashi, Arisa
    Nakashima, Akio
    Ohkido, Ichiro
    Yokoo, Takashi
    JOURNAL OF BONE AND MINERAL METABOLISM, 2024, 42 (02) : 264 - 270
  • [34] Long-term effects of denosumab on bone mineral density and turnover markers in patients undergoing hemodialysis
    Kazuhiko Kato
    Tatsuhiro Yaginuma
    Arisa Kobayashi
    Akio Nakashima
    Ichiro Ohkido
    Takashi Yokoo
    Journal of Bone and Mineral Metabolism, 2024, 42 : 264 - 270
  • [35] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments
    M. Kamimura
    Y. Nakamura
    S. Ikegami
    S. Uchiyama
    H. Kato
    A. Taguchi
    Osteoporosis International, 2017, 28 : 1757 - 1758
  • [36] Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients: response to comments
    Kamimura, M.
    Nakamura, Y.
    Ikegami, S.
    Uchiyama, S.
    Kato, H.
    Taguchi, A.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 (05) : 1757 - 1758
  • [37] Meta-analysis of the effects of denosumab and romosozumab on bone mineral density and turnover markers in patients with osteoporosis
    Hu, Mingwei
    Zhang, Yifan
    Guo, Jianjun
    Guo, Cuicui
    Yang, Xue
    Ma, Xue
    Xu, Hao
    Xiang, Shuai
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [38] Effect of long-term oral anticoagulant therapy on bone mineral density and bone turnover markers: a prospective 12 month study
    Stenova, E.
    Steno, B.
    Killinger, Z.
    Baqi, L.
    Payer, J.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2011, 112 (02): : 71 - 76
  • [39] Denosumab in treatment-naive and pre-treated with zoledronic acid postmenopausal women with low bone mass: Effect on bone mineral density and bone turnover markers
    Anastasilakis, Athanasios D.
    Polyzos, Stergios A.
    Efstathiadou, Zoe A.
    Sauvidis, Matthaios
    Sakellariou, Grigorios T.
    Papatheoclorou, Athanasios
    Kokkoris, Panagiotis
    Makras, Polyzois
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (10): : 1291 - 1297
  • [40] Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids
    Sawamura, Masato
    Komatsuda, Atsushi
    Togashi, Masaru
    Wakui, Hideki
    Takahashi, Naoto
    INTERNAL MEDICINE, 2017, 56 (06) : 631 - 636
12345